Cardiac Insight, a University of Washington spinoff biotech company, has raised $7 million, according to its latest filing with the Securities and Exchange Commission.
The Seattle company based in the Eastlake district has focused on developing new technology that can detect a common form of irregular heartbeat known as atrial fibrillation, or a-fib.
Its core technology is a diagnostic chip enclosed in a Band-Aid-size strip that a patient wears on the skin over the heart. It’s call the Stealth…
Cardiac Insight, a University of Washington spinoff biotech company, has raised $7 million, according to its latest filing with the Securities and Exchange Commission.
The Seattle company based in the Eastlake district has focused on developing new technology that can detect a common form of irregular heartbeat known as atrial fibrillation, or a-fib.
Its core technology is a diagnostic chip enclosed in a Band-Aid-size strip that a patient wears on the skin over the heart. It’s call the Stealth…